Monopar Therapeutics
MNPR
#8837
Rank
NZ$0.14 B
Marketcap
$28.26
Share price
7.31%
Change (1 day)
799.35%
Change (1 year)

Earnings for Monopar Therapeutics (MNPR)

Earnings in 2024 (TTM): -NZ$11.7 Million

According to Monopar Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -NZ$14.07 Million, an increase over its 2022 earnings that were of -NZ$17.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monopar Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$11.7 Million-16.88%
2023 -NZ$14.07 Million-20.1%
2022 -NZ$17.61 Million15.52%
2021 -NZ$15.25 Million44.39%
2020 -NZ$10.56 Million49.23%
2019 -NZ$7.08 Million28.04%
2018 -NZ$5.53 Million-80.07%
2017 -NZ$27.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.21 Billion 1,656.23%๐Ÿ‡บ๐Ÿ‡ธ USA